Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation

Kidney International

Volumn 71, Issue 2, 2007, Pages 126-133

  Boulanger, E ^a,b   Grossin, N ^a   Wautier, M P ^a,c   Taamma, R ^d   Wautier, J L ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d Fresenius Medical Care   (France)

Author keywords

Advanced glycation end products; Endothelial cells; Mesothelial cells; Peritoneal dialysis; RAGE; VEGF

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CELL STIMULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MESOTHELIUM; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICUS;

ANTIBODIES; ANTIGENS, NEOPLASM; CAPILLARIES; COCULTURE TECHNIQUES; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; PERITONEAL DIALYSIS; PERITONEUM; SERUM ALBUMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846260239     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002016     Document Type: Article

References (31)

1. Davies SJ, Phillips L, Griffiths AM et al. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54: 2207-2217.
2. Topley N, Kaur D, Petersen MM et al. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 1996; 7: 218-224.
3. Combet S, Miyata T, Moulin P et al. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000; 11: 717-728.
4. Witowski J, Korybalska K, Wisniewska J et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000; 11: 729-739.
5. Miyata T, Horie K, Ueda Y et al. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 2000; 58: 425-435.
6. Linden T, Cohen A, Deppisch R et al. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002; 62: 697-703.
7. Boulanger E, Wautier MP, Gane P et al. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrol Dial Transplant 2004; 19: 2208-2216.
8. Boulanger E, Wautier MP, Wautier JL et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 2002; 61: 148-156.
9. Devuyst O, Nielsen S, Cosyns J et al. Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol 1998; 275: H234-H242.
10. Ferrara N, Gerber H, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
11. Pecoits Filho R, Araujo M, Lindholm B et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-1486.
12. Rougier JP, Guia S, Hagege J et al. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1. Kidney Int 1998; 54: 87-98.
13. Wautier MP, Boulanger E, Guillausseau PJ et al. AGEs, macrophage colony stimulating factor and vascular adhesion molecule blood levels are increased in patients with diabetic microangiopathy. Thromb Haemost 2004; 91: 879-885.
14. Tamarat R, Silvestre JS, Huijberts M et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci USA 2003; 100: 8555-8560.
15. Boulanger E, Moranne O, Wautier MP et al. Changes in glycation and oxidation markers in patients starting peritoneal dialysis: a pilot study. Perit Dial Int 2006; 26: 207-212.
16. Mortier S, Faict D, Lameire N et al. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 2005; 67: 1559-1565.
17. Mandl-Weber S, Cohen C, Haslinger B et al. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002; 61: 570-578.
18. Combet S, Ferrier ML, van Landschoot M et al. Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J Am Soc Nephrol 2001; 12: 2146-2157.
19. Agalou S, Ahmed N, Babaei-Jadidi R et al. Profound mishandling of protein glycation degradation products in uremia and dialysis. J Am Soc Nephrol 2005; 16: 1471-1485.
20. Thornalley PJ. Measurment of protein glycation, glycated peptide, and glycation free adducts. Perit Dial Int 2005; 25: 522-533.
21. Carmeliet P. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 2003; 4: 710-720.
22. Podar K, Anderson K. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 2005; 105: 1383-1395.
23. Mortier S, Faict D, Schalkwijk C et al. Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int 2004; 66: 1257-1265.
24. Schwenger V, Morath C, Salava A et al. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. J Am Soc Nephrol 2006; 17: 199-207.
25. Wautier MP, Chappey O, Corda S et al. Activation of NADPH oxidase by advanced glycation end-products (AGEs) links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280: E685-E694.
26. Schmidt AM, Hori O, Chen JX et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395-1403.
27. Wautier JL, Paton RC, Wautier MP et al. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 1981; 305: 237-242.
28. Wautier MP, Massin P, Guillausseau PJ et al. N(carboxymethyl) lysine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes Metab 2003; 29: 44-52.
29. Teerlink T, Barto R, Ten Brink H et al. Measurement of Nepsilon-(carboxymethyl) lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry. Clin Chem 2004; 50: 1116-1117.
30. Wellmann S, Taube T, Paal K et al. Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by lightcycler technology. Clin Chem 2001; 47: 654-660.
31. Rosner B, Glynn R, Lee M. The Wilcoxon signed rank test for paired comparisons of clustered data. Biometrics 2006; 62: 185-192.